{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    9,
    10,
    11,
    13,
    14,
    16,
    19,
    30,
    31,
    32,
    38,
    45,
    48,
    51,
    52
  ],
  "modelUsed": "gemini-3-flash-preview",
  "confidence": 1.0,
  "documentStructure": {
    "documentContentReferences": [
      {
        "id": "ref_1",
        "name": "Eligibility Criteria Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "5.1",
        "sectionTitle": "ELIGIBILITY CRITERIA",
        "description": "Cross-reference to eligibility criteria from the Overall Study Design section."
      },
      {
        "id": "ref_2",
        "name": "Safety Monitoring Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "3.11, 3.14, 3.15",
        "sectionTitle": "Operations Manual",
        "description": "Reference to clinical laboratory test results, ECGs, and vital signs in Appendix F."
      },
      {
        "id": "ref_3",
        "name": "Study Design Schematic",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "Figure 1",
        "sectionTitle": "Study Design Schematic",
        "description": "Internal link to the study design visual representation."
      },
      {
        "id": "ref_4",
        "name": "Prohibited Medications Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "5.3",
        "sectionTitle": "PROHIBITED MEDICATIONS AND THERAPY",
        "description": "Reference for details on discontinuing prohibited medications."
      },
      {
        "id": "ref_5",
        "name": "Dose Conversion Reference",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "4.2",
        "sectionTitle": "Discussion of Study Design",
        "description": "Reference to conversion algorithm based on Phase 1 studies."
      },
      {
        "id": "ref_6",
        "name": "Infusion Site Evaluation Scale",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "3.6",
        "sectionTitle": "Operations Manual",
        "description": "Reference to the numeric grade scale for skin irritation in Appendix F."
      },
      {
        "id": "ref_7",
        "name": "Follow-up Information",
        "instanceType": "DocumentContentReference",
        "sectionNumber": "5.7",
        "sectionTitle": "FOLLOW-UP AFTER SUBJECT DISCONTINUATION",
        "description": "Reference for additional information on post-treatment activities."
      }
    ],
    "commentAnnotations": [
      {
        "id": "annot_1",
        "text": "The Screening Period may be extended up to a total of 90 days for extenuating circumstances, e.g., supply constraints.",
        "annotationType": "Footnote",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Figure 1. Study Design Schematic",
        "pageNumber": 11
      },
      {
        "id": "annot_2",
        "text": "As allowed by local regulations, subjects will receive the PKG-watch following Screening Visit 1 (V1) and will be required to wear it during the Monitoring Period.",
        "annotationType": "Note",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Figure 1. Study Design Schematic",
        "pageNumber": 11
      },
      {
        "id": "annot_3",
        "text": "Software version 'DL.v01.05' is installed on the pumps.",
        "annotationType": "Footnote",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Table 9. Identity of Study Devices",
        "pageNumber": 33
      },
      {
        "id": "annot_4",
        "text": "Subjects enrolled under protocol v6.0 (or after) will use the Neria Guard infusion set at the start of enrollment.",
        "annotationType": "Footnote",
        "instanceType": "CommentAnnotation",
        "sourceSection": "Table 9. Identity of Study Devices",
        "pageNumber": 33
      }
    ],
    "studyDefinitionDocumentVersions": [
      {
        "id": "ver_1",
        "versionNumber": "7.0",
        "status": "Approved",
        "instanceType": "StudyDefinitionDocumentVersion",
        "versionDate": "2021-02-11",
        "description": "Current version identified in page headers and Appendix B."
      },
      {
        "id": "ver_2",
        "versionNumber": "6.0",
        "status": "Final",
        "instanceType": "StudyDefinitionDocumentVersion",
        "description": "Historical version referenced in Table 9 footnotes regarding subject enrollment transitions."
      }
    ],
    "summary": {
      "referenceCount": 7,
      "annotationCount": 4,
      "versionCount": 2
    }
  }
}